OurCrowd logo

OurCrowd

Asia, Yerushalayim, Israel, Jerusalem

Description

OurCrowd is a prominent global venture investing platform headquartered in Jerusalem, Israel, that uniquely blends elements of traditional venture capital with equity crowdfunding. Founded in 2013, the platform enables accredited investors, including institutions and individuals, to invest in high-growth startups, venture funds, and other alternative assets. OurCrowd's distinctive model involves performing extensive due diligence on potential portfolio companies, investing its own capital alongside the crowd, and then syndicating these opportunities to its vast network of investors worldwide.

The platform primarily focuses on early-stage companies, typically participating in Seed, Series A, and Series B rounds. Their investment thesis spans a wide array of sectors, with a notable emphasis on deep technology, artificial intelligence, cybersecurity, health tech, agritech, and fintech. OurCrowd acts as an active investor, often taking board seats and providing strategic guidance to its portfolio companies, leveraging its global network for mentorship and business development. This hands-on approach aims to mitigate risks and enhance the potential for successful exits.

OurCrowd has demonstrated significant scale and impact within the global venture ecosystem. As of early 2024, the platform has facilitated over $2.2 billion in investments, supporting more than 400 companies and 50 venture funds across various industries and geographies. While the platform allows individual investors to participate with minimum investments typically starting at $10,000, OurCrowd's own direct first cheque into a company generally ranges from $1 million to $10 million, depending on the stage and the overall size of the funding round. This direct investment signals strong conviction and often serves as a catalyst for broader participation from their investor network.

OurCrowd's hybrid model has positioned it as a significant player, democratizing access to venture capital investments while maintaining a rigorous selection process. It provides a crucial bridge between innovative startups seeking capital and a diverse pool of investors looking for exposure to high-growth private companies, thereby fostering innovation and economic growth on a global scale.

Investor Profile

OurCrowd has backed more than 235 startups, with 4 new investments in the last 12 months alone. The firm has led 28 rounds, about 12% of its total and boasts 54 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in Israel, United States, United Kingdom.
  • Strong thematic focus on Software, Artificial Intelligence (AI), Analytics.
  • Led 2 rounds in the past year.
  • Typical check size: $1M – $10M.

Stage Focus

  • Series B (26%)
  • Series A (24%)
  • Seed (15%)
  • Series C (14%)
  • Series Unknown (8%)
  • Series D (5%)
  • Convertible Note (3%)
  • Series E (2%)
  • Series F (1%)

Country Focus

  • Israel (48%)
  • United States (40%)
  • United Kingdom (3%)
  • New Zealand (3%)
  • Singapore (2%)
  • Canada (1%)
  • Italy (1%)
  • India (1%)

Industry Focus

  • Software
  • Artificial Intelligence (Ai)
  • Analytics
  • Machine Learning
  • Health Care
  • Information Technology
  • Saas
  • Fintech
  • Medical
  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does OurCrowd frequently co-invest with?

Viola Ventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 7
Finistere Ventures
North America, California, United States, San Diego
Co-Investments: 15
Mindset Ventures
South America, Sao Paulo, Brazil, São Paulo
Co-Investments: 7
Vertex Ventures
Asia, Central Region, Singapore, Singapore
Co-Investments: 6
Next Gear Ventures
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 8
iAngels
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 7
Changer Club
Europe, Vaud, Switzerland, Lausanne
Co-Investments: 7
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 10
Jerusalem Venture Partners (JVP)
Asia, Yerushalayim, Israel, Jerusalem
Co-Investments: 9
Decacorn Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 7

Which angels does OurCrowd often collaborate with?

PG
North America, California, United States, San Francisco
Shared Deals: 3
GC
Europe, Piemonte, Italy, Turin
Shared Deals: 2
MB
North America, California, United States, San Francisco
Shared Deals: 3
ED
North America, New York, United States, New York
Shared Deals: 2
Zohar Zisapel
Asia, Tel Aviv, Israel, Tel Aviv
Shared Deals: 3
MM
North America, Texas, United States, Dallas
Shared Deals: 3
Eyal Gura
Asia, Israel
Shared Deals: 5
Li Ka-shing
Asia, Hong Kong Island, Hong Kong, Hong Kong
Shared Deals: 2
Yair Tauman
Asia, Israel
Shared Deals: 2
AP
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by OurCrowd?

BioLumic

Palmerston North, Wellington, New Zealand

BioLumic unlocks the natural genetic potential of seeds and seedlings with specialized light treatments, data science, and technology.

AgricultureAgTechBiotechnologyCannabisSustainability
Series BApr 22, 2025
Amount Raised: $8,300,000
Lidwave

Jerusalem, Yerushalayim, Israel

Disruptive 3D Sensing Architecture

3D TechnologyHardwareManufacturingSensor
SeedOct 14, 2024
Amount Raised: $10,000,000
Kando

Kokhav Ya'ir, HaMerkaz, Israel

Kando provides wastewater intelligence solutions for optimizing treatment processes.

Artificial Intelligence (AI)Information TechnologyWaste ManagementWater
Series UnknownOct 4, 2024
Amount Raised: $10,000,000
Blue Tree Technologies Ltd.

Kiryat Gat, HaDarom, Israel

Blue Tree’s mission is to develop a sugar reduction platform for industrial applications in the drinks industry.

Food and Beverage
SeedJul 30, 2024
Amount Raised: $2,260,000
CytoReason

Tel Aviv, Tel Aviv, Israel

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series BJul 17, 2024
Amount Raised: $80,000,000
Metrovate

Auckland, Auckland, New Zealand

Metrovate is a biotechnology company which enhance global health and sustainability via sophisticated research and development.

AgricultureBioinformaticsSustainability
SeedMay 16, 2024
Amount Raised: $612,395
Jooules

Wellington, Wellington, New Zealand

Jooules offers a sustainable food system to ensure a greener, healthier future.

BiotechnologyEnvironmental ConsultingFood and Beverage
Pre SeedMay 1, 2024
Amount Raised: $593,309
Carrar

Sderot, HaDarom, Israel

Carrar manufactures and designs a wide range of thermal management technology systems for the electric mobility industry.

AutomotiveElectric VehicleEnergy EfficiencyManufacturingProduct Design
Series AApr 9, 2024
Amount Raised: $5,300,000
NeuReality

Caesarea, Hefa, Israel

NeuReality is a semiconductor start-up that designs AI-as-a-service infrastructure.

Artificial Intelligence (AI)Machine LearningSoftware
Series AMar 19, 2024
Amount Raised: $20,000,000
Ori Industries

London, England, United Kingdom

Ori is a GPU cloud computing and ML development platform for training, serving and scaling machine learning models.

Artificial Intelligence (AI)Cloud ComputingDevOpsGPUInfrastructureIT InfrastructureMachine LearningMobile
Convertible NoteFeb 4, 2024
Amount Raised: $25,000,000